Early in the course of Alzheimer's disease--long before future patients begin to notice symptoms--neurofibrillary tangles composed of tau protein aggregates begin to form in their brain cells. How toxic these aggregates are and how well they spread depend on their size. However, scientists studying tangle formation have not been able to explain why different sizes of cable-like tau aggregates appear in disease.
But now, researchers have discovered that instead of adding just one protein at a time, fibrils of various lengths can join end-to-end to create one longer filament. The finding, which will appear in the Journal of Biological Chemistry, helps explain how fibrils can grow to hundreds of nanometers and could also help researchers understand mechanisms of an emerging group of drug candidates designed to inhibit tau aggregation.
Scientists can use mathematical models to describe biological processes such as fibril formation. A common simple model of tau aggregation includes two steps. In the first step, two tau proteins bind slowly, and, in the second step, additional tau molecules latch on quickly.
First author of the study set out to expand this mathematical model to include other known ways that tau fibrils behave. Scientists have observed, for example, that sometimes one fibril fragments into two. Other times, a new fibril can nucleate in the middle of an existing fibril.
The simple two-step model predicted that a test tube filled with purified tau protein would result in a large number of short fibrils. But when researchers look at aggregated tau protein under a microscope, they see a smaller number of long fibrils. That discrepancy suggested that something was happening in the real world that hadn't been accounted for in the model. They hypothesized that perhaps short fibrils could attach end-to-end to get longer.
They ran a series of experiments to test the hypothesis. In one, first they labeled tau proteins with three different fluorescent colors and allowed them to aggregate in separate test tubes. Then they mixed these different colored fibrils together in a fourth test tube.
Images taken with a super-resolution fluorescence microscope showed long fibrils with short sections of each color, indicating that fibrils from original test tubes must have joined ends to form longer fibrils. Control experiments established that this can't be explained by labeled molecules' preference for like labels.
After this new mechanism was incorporated into the model, it produced a much better description of what purified tau proteins were really doing as they formed aggregates. This study is the first to show that the fibrils can elongate by more than a single tau protein at a time.
Alzheimer's researchers are still trying to discern whether tau fibrils are a cause or simply an effect of the disease. One possibility is that transmission of fibrils from one cell to another may contribute to the spread of disease in the brain. A very long fibril, according is unlikely to spread in this way. "But once it's broken up into little pieces, those can diffuse, facilitating their movement from cell to cell."
This study used just one type of tau. Six isoforms of different length are known, and phosphorylation and other changes increase the protein's complexity. The researchers plan to incorporate these variables in future work, and to begin to use the model to understand how tau inhibitors change the protein aggregates' behavior.
http://www.jbc.org/content/early/2019/02/11/jbc.RA118.006943.abstract?sid=1d41c266-1ebc-46ef-82a9-d5888e8c1f8d
New mechanism for growth of tau aggregates in Alzheimer's
- 2,179 views
- Added
Edited
Latest News
Microfluidic systems resemb…
By newseditor
Posted 11 May
Neurotransmitter classifica…
By newseditor
Posted 11 May
Uncovering the secret of lo…
By newseditor
Posted 10 May
A cubic-millimeter fragment…
By newseditor
Posted 10 May
mtDNA transcription Inhibit…
By newseditor
Posted 09 May
Other Top Stories
The reward system synapses mature poorly in autism
Read more
Neonatal hypoxia affects learning and neuronal firing!
Read more
What doesn't kill you makes you stronger!
Read more
Could vitamin B3 treat acute kidney injury?
Read more
MicroRNA (miRNA) misregulation in Huntington's disease
Read more
Protocols
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Parasympathetic neurons der…
By newseditor
Posted 07 May
Non-invasive measurements o…
By newseditor
Posted 05 May
A validation strategy to as…
By newseditor
Posted 04 May
Publications
Vascular network-inspired f…
By newseditor
Posted 11 May
Neurotransmitter classifica…
By newseditor
Posted 11 May
Forward programming human p…
By newseditor
Posted 10 May
Cyclophilin A supports tran…
By newseditor
Posted 10 May
Sortases: structure, mechan…
By newseditor
Posted 10 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar